Phase I clinical trial of safety comparison between the generic and the original regorafenib tablets

Tong Yuanxu, Li Yan, Wei Yali, Qi Lu, Liu Chen, Li Shuang, Wang Xinghe

PDF(366 KB)
PDF(366 KB)
Adverse Drug Reactions Journal ›› 2022, Vol. 24 ›› Issue (6) : 308-313. DOI: 10.3760/cma.j.cn114015-20220224-00149

Phase I clinical trial of safety comparison between the generic and the original regorafenib tablets

    {{javascript:window.custom_author_en_index=0;}}
  • {{article.zuoZhe_EN}}
Author information +
History +

HeighLight

{{article.keyPoints_en}}

Abstract

{{article.zhaiyao_en}}

Key words

QR code of this article

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations
{{article.zuoZheEn_L}}. {{article.title_en}}. {{journal.qiKanMingCheng_EN}}. 2022, 24(6): 308-313 https://doi.org/10.3760/cma.j.cn114015-20220224-00149

References

Publishing order | Descend order by publishing year | Descend order by cited within

References

{{article.reference}}

Funding

RIGHTS & PERMISSIONS

{{article.copyrightStatement_en}}
{{article.copyrightLicense_en}}
PDF(366 KB)

Accesses

Citation

Detail
Sections
Recommended

/

〈 〉